Galafold emergency pharmacy for tvhs
Ended Awarded Last action
- Contract number
- 36C24926F0108
- Awardee
-
Amicus Therapeutics US, LLC UEI KLJFGENKMD89
- Awarding agency
-
Veterans Integrated Service Network 9
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $68,519
Award facts
- Contract value 100% obligated
- $68,518.83 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Philadelphia, PA 19104, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 9 (VISN 9), awarded a delivery order valued at $68.5K to Amicus Therapeutics US, LLC for emergency pharmacy supply of Galafold (migalastat 123 mg), an FDA-approved enzyme replacement therapy for the treatment of Fabry disease. This firm fixed-price delivery order, with an ultimate completion date of June 4, 2026, will be performed in Philadelphia, PA. The award carries no set-aside designation and represents a continuation of Amicus Therapeutics' established role as the primary supplier of this specialized rare disease medication to the Veterans Health Administration.
This delivery order operates as a child contract under Amicus Therapeutics' parent Federal Supply Schedule contract (36F79724D0185) for Pharmaceuticals and Drugs (FSS-61-IB), valued at $13M and effective through August 31, 2029. Amicus Therapeutics has consistently supplied Galafold to multiple VISNs across the country through over 150 prior delivery orders since March 2021, demonstrating the critical nature of this specialized medication within VA healthcare. The company maintains full performance responsibility as the prime contractor with no subcontractor involvement, ensuring direct control over the supply chain for this essential treatment supporting veterans with rare genetic disease conditions.
Quick answers
Who was awarded contract 36C24926F0108?
36C24926F0108 was awarded to Amicus Therapeutics US, LLC by Veterans Integrated Service Network 9 (Veterans Health Administration) on March 4, 2026.
How much is contract 36C24926F0108 worth?
The government has obligated $68,519 on 36C24926F0108.
Is contract 36C24926F0108 an order under another contract?
Yes. 36C24926F0108 is a delivery order under 36F79724D0185, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24926F0108 competed?
The extent of competition for 36C24926F0108 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award